Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 9Unknown 6Recruiting 5Not yet recruiting 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1Breast 1

Conditions

Melanoma 1Malignant Female Reproductive System Neoplasm 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Rehabilitation × Clear all
NCT07608445 2026-05-27

Physiatry-Led Cancer Prehabilitation During Neoadjuvant Systemic Therapy to Improve Function in Stage III-IVA Gynecologic Cancer Patients

City of Hope Medical Center

Phase NA Not yet recruiting
25 enrolled

Malignant Female Reproductive System Neoplasm

NCT07320222 2026-01-06

CARE-Melanoma

McMaster University

Phase 1 Not yet recruiting
30 enrolled
Dermatologic

Melanoma

NCT06881940 2025-03-18

CARPTOX-BC

Instituto Nacional de Cardiologia Ignacio Chavez

Phase NA Not yet recruiting
284 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡